Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Adenocarcinoma"" wg kryterium: Temat


Tytuł:
Pulmonary invasive mucinous adenocarcinoma.
Autorzy:
Chang WC; Department of Pathology, Taipei Medical University Hospital, Taipei, Taiwan.; Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Zhang YZ; Department of Histopathology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College, London, UK.
Nicholson AG; Department of Histopathology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College, London, UK.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2024 Jan; Vol. 84 (1), pp. 18-31. Date of Electronic Publication: 2023 Oct 22.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Lung Neoplasms*/pathology
Adenocarcinoma of Lung*
Adenocarcinoma, Mucinous*/pathology
Adenocarcinoma*/genetics
Adenocarcinoma*/pathology
Humans ; Mutation
Czasopismo naukowe
Tytuł:
Development and validation of a decision tree for distinguishing pulmonary adenocarcinomas with mucinous features and metastatic colorectal adenocarcinoma.
Autorzy:
Wein AN; Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Lin CY; Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Ritter JH; Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Bernadt CT; Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Pokaż więcej
Źródło:
Cancer cytopathology [Cancer Cytopathol] 2023 Dec; Vol. 131 (12), pp. 781-790. Date of Electronic Publication: 2023 Sep 07.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/diagnosis
Adenocarcinoma of Lung*/diagnosis
Colorectal Neoplasms*/diagnosis
Adenocarcinoma, Mucinous*/diagnosis
Lung Neoplasms*/pathology
Humans ; Keratins ; Biomarkers, Tumor ; Decision Trees ; Diagnosis, Differential
Czasopismo naukowe
Tytuł:
Prognostic factors for invasive mucinous adenocarcinoma of the lung: systematic review and meta-analysis.
Autorzy:
Zhao T; Department of Respiratory and Critical Care Medicine, The Affiliated Hospital, Southwest Medical University, 646099, Luzhou, Sichuan, China.; Inflammation & Allergic Diseases Research Unit, The Affiliated Hospital, Southwest Medical University, 646099, Luzhou, Sichuan, China.
Yi J; Department of Respiratory and Critical Care Medicine, The Affiliated Hospital, Southwest Medical University, 646099, Luzhou, Sichuan, China.; Inflammation & Allergic Diseases Research Unit, The Affiliated Hospital, Southwest Medical University, 646099, Luzhou, Sichuan, China.
Luo D; Department of Respiratory and Critical Care Medicine, The Affiliated Hospital, Southwest Medical University, 646099, Luzhou, Sichuan, China.; Faculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicine and University Hospital, Macau University of Science and Technology, Taipa, 999078, Macao, China.; Inflammation & Allergic Diseases Research Unit, The Affiliated Hospital, Southwest Medical University, 646099, Luzhou, Sichuan, China.
Liu J; Department of Respiratory and Critical Care Medicine, The Affiliated Hospital, Southwest Medical University, 646099, Luzhou, Sichuan, China.; Inflammation & Allergic Diseases Research Unit, The Affiliated Hospital, Southwest Medical University, 646099, Luzhou, Sichuan, China.
Fan X; Department of Respiratory and Critical Care Medicine, The Affiliated Hospital, Southwest Medical University, 646099, Luzhou, Sichuan, China. .; Inflammation & Allergic Diseases Research Unit, The Affiliated Hospital, Southwest Medical University, 646099, Luzhou, Sichuan, China. .
Wu Q; Faculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicine and University Hospital, Macau University of Science and Technology, Taipa, 999078, Macao, China. .; Zhuhai MUST Science and Technology Research Institute, 51900, Zhuhai, Guangdong, China. .
Wang W; Department of Respiratory and Critical Care Medicine, The Affiliated Hospital, Southwest Medical University, 646099, Luzhou, Sichuan, China. .; Inflammation & Allergic Diseases Research Unit, The Affiliated Hospital, Southwest Medical University, 646099, Luzhou, Sichuan, China. .
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2024 Feb 02; Vol. 22 (1), pp. 41. Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Adenocarcinoma of Lung*/pathology
Adenocarcinoma, Mucinous*/surgery
Adenocarcinoma, Mucinous*/pathology
Lung Neoplasms*/pathology
Pneumonia*/pathology
Humans ; Lung/pathology ; Lymphatic Metastasis ; Neoplasm Staging ; Prognosis ; Retrospective Studies ; Male ; Female
Czasopismo naukowe
Tytuł:
Data mining-based identification of epigenetic signatures with discrimination potential of lung adenocarcinoma and squamous cell carcinoma.
Autorzy:
Pang WG; Department of Thoracic Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.; Department of Thoracic Surgery, Jiangmen Central Hospital, Affiliated Jiangmen Hospital of Sun Yat-sen University, Jiangmen, 529030, China.
Ye M; Department of Thoracic Surgery, Jiangmen Central Hospital, Affiliated Jiangmen Hospital of Sun Yat-sen University, Jiangmen, 529030, China.
Chen JR; Department of Oncology, Jiangmen Central Hospital, Affiliated Jiangmen Hospital of Sun Yat-sen University, Jiangmen, 529030, China.
Zhang L; Translational Medicine Center, Maternal and Child Health Research Institute, Guangdong Women and Children Hospital, 521 Xingnan Road, Guangzhou, 511400, China. .
Wang Z; Department of Thoracic Surgery, The 2nd Clinical Medical College of Jinan University, 1017 Dongmen North Road, Luohu District, Shenzhen, 518020, China. Dr_.
Pokaż więcej
Źródło:
Molecular biology reports [Mol Biol Rep] 2024 Feb 01; Vol. 51 (1), pp. 255. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/pathology
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/genetics
Carcinoma, Squamous Cell*/genetics
Humans ; Pilot Projects ; DNA Methylation/genetics ; Epigenesis, Genetic/genetics ; Biomarkers, Tumor/genetics
Czasopismo naukowe
Tytuł:
Prognostic value of predominant subtype in pathological stage II-III lung adenocarcinoma with epidermal growth factor receptor mutation.
Autorzy:
Kitagawa S; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Zenke Y; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Taki T; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
Aokage K; Department of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Japan.
Sakai T; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Shibata Y; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Izumi H; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Nosaki K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Umemura S; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Matsumoto S; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Yoh K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Sakamoto N; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
Sakashita S; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
Kojima M; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
Tsuboi M; Department of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Japan.
Goto K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Ishii G; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan. Electronic address: .
Pokaż więcej
Źródło:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Feb; Vol. 188, pp. 107453. Date of Electronic Publication: 2023 Dec 30.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/pathology
Humans ; Male ; ErbB Receptors/genetics ; ErbB Receptors/metabolism ; Mutation ; Prognosis ; Retrospective Studies ; Tumor Microenvironment/genetics
Czasopismo naukowe
Tytuł:
Dynamic Analysis of the Impact of Micropapillary Component on Different Recurrence Patterns of Pathological Stage IA3 Lung Adenocarcinoma: A Multicenter, Retrospective Study.
Autorzy:
Xu SJ; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China.; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, Fujian Province, China.; Key Laboratory of Cardio-Thoracic Surgery, Fujian Medical University, Fujian Province University, Fuzhou, Fujian Province, China.
Chen C; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China.; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, Fujian Province, China.; Key Laboratory of Cardio-Thoracic Surgery, Fujian Medical University, Fujian Province University, Fuzhou, Fujian Province, China.
Tu JH; Department of Thoracic Surgery, The First Hospital of Putian, Putian, Fujian Province, China.
You CX; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China.; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, Fujian Province, China.; Key Laboratory of Cardio-Thoracic Surgery, Fujian Medical University, Fujian Province University, Fuzhou, Fujian Province, China.
Chen RQ; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China.; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, Fujian Province, China.; Key Laboratory of Cardio-Thoracic Surgery, Fujian Medical University, Fujian Province University, Fuzhou, Fujian Province, China.
Zhang ZF; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China.; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, Fujian Province, China.; Key Laboratory of Cardio-Thoracic Surgery, Fujian Medical University, Fujian Province University, Fuzhou, Fujian Province, China.
Chen SC; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China. .; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, Fujian Province, China. .; Key Laboratory of Cardio-Thoracic Surgery, Fujian Medical University, Fujian Province University, Fuzhou, Fujian Province, China. .
Pokaż więcej
Źródło:
Annals of surgical oncology [Ann Surg Oncol] 2024 Feb; Vol. 31 (2), pp. 872-882. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Lung Neoplasms*/pathology
Adenocarcinoma*/surgery
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/pathology
Humans ; Retrospective Studies ; Neoplasm Staging ; Neoplasm Recurrence, Local/surgery ; Neoplasm Recurrence, Local/pathology ; Prognosis
Czasopismo naukowe
Tytuł:
Transcriptional analysis of landmark molecular pathways in lung adenocarcinoma results in a clinically relevant classification with potential therapeutic implications.
Autorzy:
Hijazo-Pechero S; Unit of Bioinformatics for Precision Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.; Preclinical and Experimental Research in Thoracic Tumors (PrETT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
Alay A; Unit of Bioinformatics for Precision Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.; Preclinical and Experimental Research in Thoracic Tumors (PrETT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Cordero D; Unit of Bioinformatics for Precision Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.; Preclinical and Experimental Research in Thoracic Tumors (PrETT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Marín R; Unit of Bioinformatics for Precision Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.; Preclinical and Experimental Research in Thoracic Tumors (PrETT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Vilariño N; Preclinical and Experimental Research in Thoracic Tumors (PrETT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Thoracic Oncology Unit, Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.; Neuro-Oncology Unit, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.
Palmero R; Preclinical and Experimental Research in Thoracic Tumors (PrETT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Thoracic Oncology Unit, Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.
Brenes J; Thoracic Oncology Unit, Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.
Montalban-Casafont A; Molecular Biology CORE, Center for Biomedical Diagnostics (CDB), Hospital Clínic de Barcelona, Spain.
Nadal E; Preclinical and Experimental Research in Thoracic Tumors (PrETT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Thoracic Oncology Unit, Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.
Solé X; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Molecular Biology CORE, Center for Biomedical Diagnostics (CDB), Hospital Clínic de Barcelona, Spain.
Pokaż więcej
Źródło:
Molecular oncology [Mol Oncol] 2024 Feb; Vol. 18 (2), pp. 453-470. Date of Electronic Publication: 2023 Dec 21.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*/genetics
Adenocarcinoma*
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Humans ; B7-H1 Antigen ; Immunotherapy
Czasopismo naukowe
Tytuł:
The role of adenocarcinoma subtypes and immunohistochemistry in predicting lymph node metastasis in early invasive lung adenocarcinoma.
Autorzy:
Xue M; Department of Thoracic Surgery, Qilu Hospital, Shandong University, Lixia District, Jinan City, Shandong Province, China.
Liu J; Department of Thoracic Surgery, Qilu Hospital, Shandong University, Lixia District, Jinan City, Shandong Province, China.
Li Z; Department of Thoracic Surgery, Qilu Hospital, Shandong University, Lixia District, Jinan City, Shandong Province, China.
Lu M; Department of Thoracic Surgery, Qilu Hospital, Shandong University, Lixia District, Jinan City, Shandong Province, China.
Zhang H; Department of Thoracic Surgery, Qilu Hospital, Shandong University, Lixia District, Jinan City, Shandong Province, China.
Liu W; Department of Thoracic Surgery, Qilu Hospital, Shandong University, Lixia District, Jinan City, Shandong Province, China.
Tian H; Department of Thoracic Surgery, Qilu Hospital, Shandong University, Lixia District, Jinan City, Shandong Province, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Jan 29; Vol. 24 (1), pp. 139. Date of Electronic Publication: 2024 Jan 29.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/surgery
Adenocarcinoma of Lung*
Lung Neoplasms*
Humans ; Immunohistochemistry ; Lymphatic Metastasis ; Nomograms ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Effect of Tegafur-Uracil in Resected Stage IB Lung Adenocarcinoma According to Presence or Absence of Epidermal Growth Factor Receptor Gene Mutation: A Retrospective Cohort Study.
Autorzy:
Aoki M; Department of General Thoracic Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Kagoshima, Japan.
Miyata R; Department of General Thoracic Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Kagoshima, Japan.
Kamimura G; Department of General Thoracic Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Kagoshima, Japan.
Harada Takeda A; Department of General Thoracic Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Kagoshima, Japan.
Suetsugu T; Department of Pulmonary Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Kagoshima, Japan.
Mizuno K; Department of Pulmonary Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Kagoshima, Japan.
Ueda K; Department of General Thoracic Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Kagoshima, Japan.
Pokaż więcej
Źródło:
Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia [Ann Thorac Cardiovasc Surg] 2024 Jan 26; Vol. 30 (1). Date of Electronic Publication: 2023 Dec 16.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/surgery
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/pathology
Humans ; Tegafur/adverse effects ; Retrospective Studies ; Genes, erbB-1 ; Treatment Outcome ; Prognosis ; Mutation ; ErbB Receptors/genetics ; Neoplasm Staging ; Chemotherapy, Adjuvant
Czasopismo naukowe
Tytuł:
Case report: Target and immunotherapy of a lung adenocarcinoma with enteric differentiation, EGFR mutation, and high microsatellite instability.
Autorzy:
Yang M; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Yu P; Department of Medicine, Geneplus Beijing, Beijing, China.
He Z; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Deng J; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Jan 25; Vol. 14, pp. 1266304. Date of Electronic Publication: 2024 Jan 25 (Print Publication: 2023).
Typ publikacji:
Case Reports
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Adenocarcinoma*/drug therapy
Adenocarcinoma*/genetics
Adenocarcinoma*/pathology
Male ; Humans ; Aged ; Mutation ; ErbB Receptors/genetics ; Microsatellite Instability ; Protein Kinase Inhibitors/therapeutic use ; Immunotherapy
Raport
Tytuł:
[Construction of a Prognostic Prediction Model of Patients with Pathologic N0 
in Resected Invasive Mucinous Adenocarcinoma of the Lung].
Autorzy:
Wang Z; Health Science Center, Ningbo University, Ningbo 315211, China.
He J; The Affiliated Lihuili Hospital of Ningbo University, 
Ningbo 315048, China.
Shen H; Ningbo No.2 Hospital, Ningbo 315099, China.
Chen X; Health Science Center, Ningbo University, Ningbo 315211, China.
Lin C; The Affiliated Lihuili Hospital of Ningbo University, 
Ningbo 315048, China.
Yu H; The Affiliated Lihuili Hospital of Ningbo University, 
Ningbo 315048, China.
Gao J; Health Science Center, Ningbo University, Ningbo 315211, China.
He X; Health Science Center, Ningbo University, Ningbo 315211, China.
Shen W; The Affiliated Lihuili Hospital of Ningbo University, 
Ningbo 315048, China.
Pokaż więcej
Źródło:
Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2024 Jan 20; Vol. 27 (1), pp. 47-55.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Lung Neoplasms*/pathology
Adenocarcinoma, Mucinous*/surgery
Adenocarcinoma, Mucinous*/pathology
Adenocarcinoma of Lung*/surgery
Adenocarcinoma of Lung*/pathology
Humans ; Prognosis ; Neoplasm Staging ; Lung/pathology ; Retrospective Studies
Czasopismo naukowe
Tytuł:
FSTL3 is associated with prognosis and immune cell infiltration in lung adenocarcinoma.
Autorzy:
Meng X; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Panjiayuan, Nanli 17, Beijing, 100021, People's Republic of China.
Zhao X; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Panjiayuan, Nanli 17, Beijing, 100021, People's Republic of China.
Zhou B; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Panjiayuan, Nanli 17, Beijing, 100021, People's Republic of China.
Song W; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Panjiayuan, Nanli 17, Beijing, 100021, People's Republic of China.
Liang Y; Department of Thoracic Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, 107 Yanjiang West Road, Guangzhou, 510120, China.
Liang M; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Panjiayuan, Nanli 17, Beijing, 100021, People's Republic of China.
Du M; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Panjiayuan, Nanli 17, Beijing, 100021, People's Republic of China.
Shi J; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Panjiayuan, Nanli 17, Beijing, 100021, People's Republic of China.
Gao Y; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Panjiayuan, Nanli 17, Beijing, 100021, People's Republic of China. .
Pokaż więcej
Źródło:
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Jan 19; Vol. 150 (1), pp. 17. Date of Electronic Publication: 2024 Jan 19.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*/genetics
Adenocarcinoma*/genetics
Lung Neoplasms*/genetics
Humans ; Prognosis ; B-Lymphocytes
Czasopismo naukowe
Tytuł:
Evolutionary proteogenomic landscape from pre-invasive to invasive lung adenocarcinoma.
Autorzy:
Zhang Y; Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Institute of Thoracic Oncology, Fudan University, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China. Electronic address: .
Fu F; Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Institute of Thoracic Oncology, Fudan University, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China. Electronic address: .
Zhang Q; State Key Laboratory of Genetic Engineering and Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Institutes of Biomedical Sciences, Human Phenome Institute, Fudan University, Shanghai 200433, China.
Li L; State Key Laboratory of Genetic Engineering and Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Institutes of Biomedical Sciences, Human Phenome Institute, Fudan University, Shanghai 200433, China.
Liu H; State Key Laboratory of Genetic Engineering and Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Institutes of Biomedical Sciences, Human Phenome Institute, Fudan University, Shanghai 200433, China; State Key Laboratory Cell Differentiation and Regulation, Overseas Expertise Introduction Center for Discipline Innovation of Pulmonary Fibrosis (111 Project), College of Life Science, Henan Normal University, Xinxiang, Henan 453007, China.
Deng C; Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Institute of Thoracic Oncology, Fudan University, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Xue Q; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Zhao Y; Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Institute of Thoracic Oncology, Fudan University, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Sun W; Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Institute of Thoracic Oncology, Fudan University, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Han H; Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Institute of Thoracic Oncology, Fudan University, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Gao Z; Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Institute of Thoracic Oncology, Fudan University, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Guo C; State Key Laboratory of Genetic Engineering and Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Institutes of Biomedical Sciences, Human Phenome Institute, Fudan University, Shanghai 200433, China.
Zheng Q; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Hu H; Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Institute of Thoracic Oncology, Fudan University, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Sun Y; Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Institute of Thoracic Oncology, Fudan University, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Li Y; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China. Electronic address: .
Ding C; State Key Laboratory of Genetic Engineering and Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Institutes of Biomedical Sciences, Human Phenome Institute, Fudan University, Shanghai 200433, China. Electronic address: .
Chen H; Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Institute of Thoracic Oncology, Fudan University, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China. Electronic address: .
Pokaż więcej
Źródło:
Cell reports. Medicine [Cell Rep Med] 2024 Jan 16; Vol. 5 (1), pp. 101358. Date of Electronic Publication: 2024 Jan 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Proteogenomics*
Lung Neoplasms*/pathology
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/pathology
Adenocarcinoma*/genetics
Humans ; Proteomics ; Endothelial Cells/metabolism
Czasopismo naukowe
Tytuł:
The value of CT shape quantification in predicting pathological classification of lung adenocarcinoma.
Autorzy:
Guo M; Department of Thoracic Surgery, The First Affiliated Hospital of Henan University, Longting District, 475000, Kaifeng, Henan Province, China.
Cao Z; Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, 450000, Zhengzhou, China.
Huang Z; Department of Thoracic Surgery, The First Affiliated Hospital of Henan University, Longting District, 475000, Kaifeng, Henan Province, China.
Hu S; Department of Clinical Medicine, Medical School of Henan University, Kaifeng, China.
Xiao Y; Department of Clinical Medicine, Medical School of Henan University, Kaifeng, China.
Ding Q; Department of Thoracic Surgery, The First Affiliated Hospital of Henan University, Longting District, 475000, Kaifeng, Henan Province, China.
Liu Y; Department of Thoracic Surgery, The First Affiliated Hospital of Henan University, Longting District, 475000, Kaifeng, Henan Province, China.
An X; Department of Thoracic Surgery, The First Affiliated Hospital of Henan University, Longting District, 475000, Kaifeng, Henan Province, China.
Zheng X; Department of Thoracic Surgery, The First Affiliated Hospital of Henan University, Longting District, 475000, Kaifeng, Henan Province, China.
Zhang S; Department of Thoracic Surgery, The First Affiliated Hospital of Henan University, Longting District, 475000, Kaifeng, Henan Province, China.
Zhang G; Department of Thoracic Surgery, The First Affiliated Hospital of Henan University, Longting District, 475000, Kaifeng, Henan Province, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Jan 04; Vol. 24 (1), pp. 35. Date of Electronic Publication: 2024 Jan 04.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/pathology
Adenocarcinoma of Lung*/diagnostic imaging
Adenocarcinoma of Lung*/pathology
Adenocarcinoma*/diagnostic imaging
Adenocarcinoma*/pathology
Humans ; Tomography, X-Ray Computed/methods ; Neoplasm Invasiveness ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Screening of novel tumor-associated antigens for lung adenocarcinoma mRNA vaccine development based on pyroptosis phenotype genes.
Autorzy:
Zhou F; Department of Thoracic Surgery, Tianjin Chest Hospital of Tianjin University, 261 Taierzhuang South Road, Jinnan District, Tianjin, 300222, China.
Wang M; Department of Thoracic Surgery, Tianjin Chest Hospital of Tianjin University, 261 Taierzhuang South Road, Jinnan District, Tianjin, 300222, China.
Wang Z; Department of Thoracic Surgery, Tianjin Chest Hospital of Tianjin University, 261 Taierzhuang South Road, Jinnan District, Tianjin, 300222, China.
Li W; Department of Thoracic Surgery, Tianjin Chest Hospital of Tianjin University, 261 Taierzhuang South Road, Jinnan District, Tianjin, 300222, China.
Lu X; Department of Thoracic Surgery, Tianjin Chest Hospital of Tianjin University, 261 Taierzhuang South Road, Jinnan District, Tianjin, 300222, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Jan 02; Vol. 24 (1), pp. 28. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*/genetics
Adenocarcinoma*/genetics
Lung Neoplasms*/genetics
Humans ; mRNA Vaccines ; NLR Family, Pyrin Domain-Containing 3 Protein ; Pyroptosis/genetics ; DNA Copy Number Variations ; Phenotype ; Antigens, Neoplasm/genetics ; Prognosis ; Tumor Microenvironment ; Neoplasm Proteins ; CARD Signaling Adaptor Proteins
Czasopismo naukowe
Tytuł:
Vasculogenic mimicry-associated novel gene signature predicted prognosis and response to immunotherapy in lung adenocarcinoma.
Autorzy:
Zhang L; Department of General Surgery, the Second Affiliated Hospital of Bengbu Medical University, Anhui Province 233080, China.
Wu J; Anhui Province Key Laboratory of Clinical and Preclinical Research in Respiratory Disease,Molecular Diagnosis Center,First Affiliated Hospital,Bengbu Medical University, 287 Changhuai Road, Anhui, Bengbu 233004, China.
Yin WW; Department of Thoracic Surgery, the Second Affiliated Hospital of Bengbu Medical University, Anhui Province 233080, China.
Hu J; Department of Radiotherapy, the Second Affiliated Hospital of Bengbu Medical University, Anhui Province 233080, China.
Liao L; Department of Clinical Nutrition, the First People's Hospital of Yibin, Sichuan Province 644000, China.
Ma J; Bengbu Medical University, Anhui Province 233030, China.
Xu Z; Bengbu Medical University, Anhui Province 233030, China.
Wu S; Anhui Province Key Laboratory of Clinical and Preclinical Research in Respiratory Disease,Molecular Diagnosis Center,First Affiliated Hospital,Bengbu Medical University, 287 Changhuai Road, Anhui, Bengbu 233004, China; Anhui No. 2 Provincial People's Hospital, Hefei 230041, China. Electronic address: .
Pokaż więcej
Źródło:
Pathology, research and practice [Pathol Res Pract] 2024 Jan; Vol. 253, pp. 155048. Date of Electronic Publication: 2023 Dec 21.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/therapy
Adenocarcinoma*/genetics
Adenocarcinoma*/therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/therapy
Humans ; Prognosis ; Immunotherapy ; Genetic Risk Score ; Tumor Microenvironment/genetics
Czasopismo naukowe
Tytuł:
Clinicopathological significances of cribriform pattern in lung adenocarcinoma.
Autorzy:
Pyo JS; Department of Pathology, Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Gyeonggi-do, Republic of Korea.
Lee BH; Department of Internal Medicine, Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Gyeonggi-do, Republic of Korea.
Min KW; Department of Pathology, Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Gyeonggi-do, Republic of Korea.
Kim NY; Department of Internal Medicine, Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Gyeonggi-do, Republic of Korea. Electronic address: .
Pokaż więcej
Źródło:
Pathology, research and practice [Pathol Res Pract] 2024 Jan; Vol. 253, pp. 155035. Date of Electronic Publication: 2023 Dec 11.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Lung Neoplasms*/pathology
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/pathology
Humans ; Prognosis ; Mutation ; Receptor Protein-Tyrosine Kinases/genetics ; Neoplasm Staging
Czasopismo naukowe
Tytuł:
Distinct Recurrence Pattern and Survival Outcomes of Invasive Mucinous Adenocarcinoma of the Lung: The Potential Role of Local Therapy in Intrapulmonary Spread.
Autorzy:
Yoon DW; Department of Thoracic and Cardiovascular Surgery, Chung-ang University Hospital, Seoul, Korea.
Hwang S; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Hong TH; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.; Department of Digital Health, Samsung Advanced Institute for Health Science and Technology (SAIHST), Sungkyunkwan University, Seoul, Korea.; Department of Health Sciences and Technology, Samsung Advanced Institute of Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea.
Choi YL; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kim HK; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Choi YS; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kim J; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Shim YM; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Cho JH; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. .
Pokaż więcej
Źródło:
Annals of surgical oncology [Ann Surg Oncol] 2024 Jan; Vol. 31 (1), pp. 201-212. Date of Electronic Publication: 2023 Oct 09.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/surgery
Adenocarcinoma, Mucinous*/surgery
Adenocarcinoma*/pathology
Humans ; Neoplasm Recurrence, Local/surgery ; Lung/pathology ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Cytomorphology of pulmonary low-grade fetal adenocarcinoma in bronchial brushing specimen prepared by BD SurePath: A case report and literature review.
Autorzy:
Lee WY; Division of Cytopathology, Department of Pathology, Chi Mei Medical Center, Tainan, Taiwan.
Su YC; Department of Thoracic Surgery, Chi Mei Medical Center, Tainan, Taiwan.; Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University, Tainan, Taiwan.
Chuang SS; Department of Pathology, Chi Mei Medical Center, Tainan, Taiwan.
Pokaż więcej
Źródło:
Diagnostic cytopathology [Diagn Cytopathol] 2024 Jan; Vol. 52 (1), pp. E7-E11. Date of Electronic Publication: 2023 Sep 25.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Lung Neoplasms*/diagnosis
Lung Neoplasms*/pathology
Adenocarcinoma of Lung*/pathology
Adenocarcinoma*/diagnosis
Adenocarcinoma*/pathology
Male ; Young Adult ; Humans ; Adult ; Lung/pathology ; Bronchi/pathology
Czasopismo naukowe
Tytuł:
Clinical, Genomic, and Transcriptomic Featurses of Lung Adenocarcinoma With Uncommon EGFR Mutation.
Autorzy:
Hayasaka K; Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan; Department of Gene Expression Regulation, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Takeda H; Department of Gene Expression Regulation, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Sakurada A; Department of Thoracic Surgery, South Miyagi Medical Center, Ogawara, Japan. Electronic address: .
Matsumura Y; Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.
Abe J; Department of Thoracic Surgery, Miyagi Cancer Center, Natori, Japan.
Shiono S; Department of Surgery II, Faculty of Medicine, Yamagata University, Yamagata, Japan.
Notsuda H; Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Suzuki H; Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.
Endo M; Department of Thoracic Surgery, Yamagata Prefectural Central Hospital, Yamagata, Japan.
Motohashi H; Department of Gene Expression Regulation, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Okada Y; Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Pokaż więcej
Źródło:
Clinical lung cancer [Clin Lung Cancer] 2024 Jan; Vol. 25 (1), pp. e43-e51. Date of Electronic Publication: 2023 Oct 18.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Lung Neoplasms*/pathology
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/surgery
Humans ; Retrospective Studies ; Prognosis ; Mutation/genetics ; ErbB Receptors/genetics ; Gene Expression Profiling ; Tumor Microenvironment
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies